In a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and non-hospital sites of care. CRA’s expert found that in most uses, during the relevant time period there was ample evidence of competition, finding that the manufacturer at issue was effectively price constrained by existing competition.
An economic approach could curb broad antitrust classes
On July 16, a federal court certified the “Cattle Plaintiffs Producer Class” in In Re Cattle and Beef Antitrust Litigation, a case alleging that Cargill, JBS,...